{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:43:41Z","timestamp":1783035821226,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40801-022-00334-2","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T16:05:40Z","timestamp":1668096340000},"page":"69-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Duloxetine Exposure During Pregnancy\u00a0and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-9255","authenticated-orcid":false,"given":"Mikkel Z\u00f6llner","family":"Ankarfeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Tr\u00e6rup","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda Scantamburlo","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Paul","family":"Motsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen","family":"Jimenez-Solem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"334_CR1","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.ajog.2005.02.103","volume":"193","author":"U Halbreich","year":"2005","unstructured":"Halbreich U. The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions: the need for interdisciplinary integration. Am J Obstet Gynecol. 2005;193:1312\u201322.","journal-title":"Am J Obstet Gynecol"},{"key":"334_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1056\/NEJM199904223401603","volume":"340","author":"DD McIntire","year":"1999","unstructured":"McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340:1234\u20138.","journal-title":"N Engl J Med"},{"key":"334_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/bmj.323.7307.257","volume":"323","author":"J Evans","year":"2001","unstructured":"Evans J, Heron J, Francomb H, et al. Cohort study of depressed mood during pregnancy and after childbirth. BMJ. 2001;323:257\u201360.","journal-title":"BMJ"},{"key":"334_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1037\/0022-006X.57.2.269","volume":"57","author":"IH Gotlib","year":"1989","unstructured":"Gotlib IH, Whiffen VE, Mount JH, et al. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol. 1989;57:269\u201374.","journal-title":"J Consult Clin Psychol"},{"key":"334_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/01.AOG.0000116689.75396.5f","volume":"103","author":"HA Bennett","year":"2004","unstructured":"Bennett HA, Einarson A, Taddio A, et al. Prevalence of depression during pregnancy: systematic review 1. Obstet Gynecol. 2004;103:698\u2013709. https:\/\/doi.org\/10.1097\/01.AOG.0000116689.75396.5f.","journal-title":"Obstet Gynecol"},{"key":"334_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.encep.2010.02.004","volume":"36","author":"O Chatillon","year":"2010","unstructured":"Chatillon O, Even C. Antepartum depression: prevalence, diagnosis and treatment. Encephale. 2010;36:443\u201351. https:\/\/doi.org\/10.1016\/j.encep.2010.02.004.","journal-title":"Encephale."},{"key":"334_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1441","author":"Y Sun","year":"2019","unstructured":"Sun Y, Dreier JW, Liu X, et al. Trend of antidepressants before, during, and after pregnancy across two decades: a population-based study. Brain Behav. 2019. https:\/\/doi.org\/10.1002\/brb3.1441.","journal-title":"Brain Behav."},{"key":"334_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063034","volume":"8","author":"E Jimenez-Solem","year":"2013","unstructured":"Jimenez-Solem E, Andersen JT, Petersen M, et al. Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study. PLoS ONE. 2013;8: e63034. https:\/\/doi.org\/10.1371\/journal.pone.0063034.","journal-title":"PLoS ONE"},{"key":"334_CR9","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","volume":"335","author":"CD Chambers","year":"1996","unstructured":"Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335:1010\u20135.","journal-title":"N Engl J Med"},{"key":"334_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/bdrb.20025","volume":"71","author":"B Kallen","year":"2004","unstructured":"Kallen B. Fluoxetine use in early pregnancy. Birth Defects Res B Dev Reprod Toxico. 2004;71:395\u20136. https:\/\/doi.org\/10.1002\/bdrb.20025.","journal-title":"Birth Defects Res B Dev Reprod Toxico"},{"key":"334_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","volume":"194","author":"SW Wen","year":"2006","unstructured":"Wen SW, Yang Q, Garner P, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006;194:961\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2006.02.019.","journal-title":"Am J Obstet Gynecol"},{"key":"334_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/chi.0b013e318047b775","volume":"2","author":"EP Davis","year":"2007","unstructured":"Davis EP, Glynn LM, Schetter CD, et al. Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry. 2007;2:737\u201346.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"334_CR13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/pds.1462","volume":"16","author":"RL Davis","year":"2007","unstructured":"Davis RL, Rubanowice D, McPhillips H, et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf. 2007;16:1086\u201394. https:\/\/doi.org\/10.1002\/pds.1462.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"334_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092778","volume":"9","author":"KF Huybrechts","year":"2014","unstructured":"Huybrechts KF, Sanghani RS, Avorn J, Urato AC. Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS ONE. 2014;9: e92778.","journal-title":"PLoS ONE"},{"key":"334_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1056\/NEJMoa052744","volume":"354","author":"CD Chambers","year":"2006","unstructured":"Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579\u201387. https:\/\/doi.org\/10.1056\/NEJMoa052744.","journal-title":"N Engl J Med"},{"key":"334_CR16","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","volume":"63","author":"TF Oberlander","year":"2006","unstructured":"Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch General Psychiatry. 2006;63:898\u2013906.","journal-title":"Arch General Psychiatry."},{"key":"334_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m237","volume":"368","author":"KF Huybrechts","year":"2020","unstructured":"Huybrechts KF, Bateman BT, Pawar A, et al. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. BMJ. 2020;368: m237. https:\/\/doi.org\/10.1136\/bmj.m237.","journal-title":"BMJ"},{"key":"334_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. https:\/\/doi.org\/10.1186\/1471-2458-11-450.","journal-title":"BMC Public Health"},{"key":"334_CR19","first-page":"263","volume":"46","author":"TF Andersen","year":"1999","unstructured":"Andersen TF, Madsen M, J\u00f8rgensen J, et al. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263\u20138.","journal-title":"Dan Med Bull"},{"key":"334_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/0895-4356(96)00018-2","volume":"49","author":"J Kristensen","year":"1996","unstructured":"Kristensen J, Langhoff-Roos J, Skovgaard LT, Kristensen FB. Validation of the Danish birth registration. J Clin Epidemiol. 1996;49:893\u20137.","journal-title":"J Clin Epidemiol"},{"key":"334_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/aogs.12302","volume":"93","author":"J Langhoff-Roos","year":"2014","unstructured":"Langhoff-Roos J, Krebs L, Klungs\u00f8yr K, et al. The Nordic medical birth registers: a potential goldmine for clinical research. Acta Obstet Gynecol Scand. 2014;93:132\u20137. https:\/\/doi.org\/10.1111\/aogs.12302.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"334_CR22","unstructured":"Centre for Epidemiology, National Board of Health and Welfare. The Swedish Medical Birth Register: a summary of content and quality. 2003."},{"key":"334_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes HW, Sorensen HT, Hallas J. The danish national prescription registry. Scand J Public Health. 2011;39:38\u201341. https:\/\/doi.org\/10.1177\/1403494810394717.","journal-title":"Scand J Public Health."},{"key":"334_CR24","first-page":"445","volume":"44","author":"D Gaist","year":"1997","unstructured":"Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44:445\u20138.","journal-title":"Dan Med Bull"},{"key":"334_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register: opportunities for pharmacoepidemiological research and experience from the first 6\u00a0months. Pharmacoepidemiol Drug Saf. 2007;16:726\u201335. https:\/\/doi.org\/10.1002\/pds.1294.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"334_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1403494811405098","volume":"39","author":"M Baadsgaard","year":"2011","unstructured":"Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39:103\u20135. https:\/\/doi.org\/10.1177\/1403494811405098.","journal-title":"Scand J Public Health."},{"key":"334_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1403494810394715","volume":"39","author":"VM Jensen","year":"2011","unstructured":"Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39:91\u20134. https:\/\/doi.org\/10.1177\/1403494810394715.","journal-title":"Scand J Public Health."},{"key":"334_CR28","doi-asserted-by":"publisher","first-page":"E310","DOI":"10.1503\/cmaj.109-4713","volume":"186","author":"PC Webster","year":"2014","unstructured":"Webster PC. Sweden\u2019s health data goldmine. CMAJ. 2014;186:E310. https:\/\/doi.org\/10.1503\/cmaj.109-4713.","journal-title":"CMAJ"},{"key":"334_CR29","unstructured":"Parsons LS. Performing a 1:N case-control match on propensity score. SUGI 29; 10 May 2004; Montr\u00e9al (QC); paper 165-29."},{"key":"334_CR30","unstructured":"Yang D, Dalton JE. A unified approach to measuring the effect size between two groups using SAS. SAS Global Forum; 22-25 April 2012; Orlando (FL); paper 335-2012."},{"key":"334_CR31","unstructured":"Dalton JE. A new standardized difference metric for multinomial samples. 2008. Unpublished work."},{"key":"334_CR32","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Available from: https:\/\/www.whocc.no\/. [Accessed 25 Oct 2019]."},{"key":"334_CR33","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2017.3413","volume":"317","author":"AC Sujan","year":"2017","unstructured":"Sujan AC, Rickert ME, \u00d6berg AS, et al. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring. JAMA. 2017;317:1553\u201362. https:\/\/doi.org\/10.1001\/jama.2017.3413.","journal-title":"JAMA"},{"key":"334_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/humrep\/den342","volume":"24","author":"D Li","year":"2009","unstructured":"Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study. Hum Reprod. 2009;24:146\u201353. https:\/\/doi.org\/10.1093\/humrep\/den342.","journal-title":"Hum Reprod"},{"key":"334_CR35","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00228-017-2269-4","volume":"73","author":"CR Tak","year":"2017","unstructured":"Tak CR, Job KM, Schoen-Gentry K, et al. The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies. Eur J Clin Pharmacol. 2017;73:1055\u201369. https:\/\/doi.org\/10.1007\/s00228-017-2269-4.","journal-title":"Eur J Clin Pharmacol"},{"key":"334_CR36","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1017\/S0033291709992194","volume":"40","author":"M Reis","year":"2010","unstructured":"Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40:1723\u201333. https:\/\/doi.org\/10.1017\/S0033291709992194.","journal-title":"Psychol Med"},{"key":"334_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.reprotox.2019.01.003","volume":"84","author":"JL Richardson","year":"2019","unstructured":"Richardson JL, Martin F, Dunstan H, et al. Pregnancy outcomes following maternal venlafaxine use: a prospective observational comparative cohort study. Reprod Toxicol. 2019;84:108\u201313. https:\/\/doi.org\/10.1016\/j.reprotox.2019.01.003.","journal-title":"Reprod Toxicol"},{"key":"334_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","volume":"371","author":"S Saigal","year":"2008","unstructured":"Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371:261\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(08)60136-1.","journal-title":"Lancet"},{"key":"334_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.siny.2015.12.007","volume":"21","author":"MS Harrison","year":"2016","unstructured":"Harrison MS, Goldenberg RL. Global burden of prematurity. Semin Fetal Neonatal Med. 2016;21:74\u20139. https:\/\/doi.org\/10.1016\/j.siny.2015.12.007.","journal-title":"Semin Fetal Neonatal Med"},{"key":"334_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003851","volume":"18","author":"MZ Ankarfeldt","year":"2021","unstructured":"Ankarfeldt MZ, Petersen J, Andersen JT, et al. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: a nationwide cohort study in Denmark and Sweden. PLoS Med. 2021;18: e1003851. https:\/\/doi.org\/10.1371\/journal.pmed.1003851.","journal-title":"PLoS Med"},{"key":"334_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40801-021-00252-9","volume":"8","author":"MZ Ankarfeldt","year":"2021","unstructured":"Ankarfeldt MZ, Petersen J, Andersen JT, et al. Duloxetine exposure during pregnancy and the risk of spontaneous and elective abortion: a Danish nationwide pbservational study. Drugs Real World Outcomes. 2021;8:289\u201399. https:\/\/doi.org\/10.1007\/s40801-021-00252-9.","journal-title":"Drugs Real World Outcomes."},{"key":"334_CR42","unstructured":"medstat.dk. Statistics of medication use in Denmark. Available from: http:\/\/medstat.dk\/. [Accessed 25 Oct 2019]."},{"key":"334_CR43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/AOG.0000000000000447","volume":"124","author":"JT Andersen","year":"2014","unstructured":"Andersen JT, Andersen NL, Horwitz H, et al. Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage. Obstet Gynecol. 2014;124:655\u201361. https:\/\/doi.org\/10.1097\/AOG.0000000000000447.","journal-title":"Obstet Gynecol"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-022-00334-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-022-00334-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-022-00334-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:50:13Z","timestamp":1677016213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-022-00334-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1007\/s40801-022-00334-2","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"15 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have participated sufficiently in the work to take public responsibility for the whole content. MZA, JP, JTA, MFSF, HL, TF, and EJS contributed with the concept and design of the study. MZA, JP, JTA, MFSF, HL, SPM, TF, and EJS contributed with the acquisition, analysis and\/or interpretation of data. MZA drafted the manuscript. JP, JTA, MFSF, HL, SPM, TF, and EJS revised the manuscript. MZA, and JP performed the statistical analysis. MFSF, HL, and SPM obtained funding. All authors read and approved the final version.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}},{"value":"This publication, including the open access fee, is funded by Eli Lilly and Company, the manufacturer of duloxetine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The researchers do not store any data and cannot hand over data. Data are available by applying to the relevant authorities in Sweden and Denmark.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"The study was performed by the Copenhagen Phase IV Unit (Phase4CPH) at the Department of Clinical Pharmacology and the Institute of Applied Economics and Health Research Aps (ApHER), and financed by Eli Lilly, the manufacturer of duloxetine. MZA, JP, and EJS have conducted other studies regarding antidepressants, involving funding from Janssen Pharmaceutical via Phase4CPH. JTA and TF have no relevant financial activities outside the submitted work. TF is a former employee of ApHER and is currently employed by Quantify Research. MFSF is a current employee of Eli Lilly and Company. HL and SPM are former employees of Eli Lilly and Company. HL is currently employed by Gilead Science Inc. and SPM is currently employed by Amgen Inc.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The present study is based on a safety study regarding duloxetine and pregnancy outcomes, with the protocol and the full study report available via the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP, EUPAS20253).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior Postings and Presentations"}},{"value":"The study was approved in Sweden by the Swedish Regional Ethics Review Board in Gothenburg (ref: 1040-17 and T782-18) and the Swedish National Board of Health and Welfare (ref: 30714\/2017), and in Denmark by the Data Protection Agency (j.nr. VD-2018-371, I-Suite nr. 6621). No approval from the Danish Research Ethics Committees for the Capital Region was needed as only national registers were used. Data were gathered and analyzed at Statistics Denmark. The article does not contain clinical studies or patient data.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}